BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
DSS
DSS, Inc.
There isn't enough reported data to score DSS yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
DSS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
DSS's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | โ |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
DSS PE Valuation
DSS has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
DSS Forward outlook
There aren't enough analyst estimates for DSS to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the stronger earnings trend. Trailing diluted EPS is down 52% for BABA versus DSS down 258%.
DSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$5.68 | -$2.09 |
| Q2 2025 | -$6.18 | -$2.74 |
| Q1 2025 | -$6.60 | +$1.58 |
| Q4 2024 | -$6.63 | +$2.17 |
| Q3 2024 | -$3.59 | +$8.07 |
| Q2 2024 | -$3.44 | +$10.40 |
| Q1 2024 | -$8.18 | +$1.19 |
| Q4 2023 | -$8.80 | +$1.23 |
DSS is still losing money, but far less than before: $5.68 per share over the past year, against $89.14 at its worst in late 2019.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over DSS on profitability, with a higher operating margin.
DSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.6M | -32% |
| Q1 2026 | $4.3M | -13% |
| Q4 2025 | $4.1M | -24% |
| Q3 2025 | $6.4M | +14% |
| Q2 2025 | $5.3M | +26% |
| Q1 2025 | $5M | +28% |
| Q4 2024 | $5.4M | +101% |
| Q3 2024 | $5.6M | +34% |
DSS's revenue has slid since its 2022 peak: $4M last quarter, down 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -105% | -40 points |
| Q1 2026 | -127% | -52 points |
| Q4 2025 | -98% | +425 points |
| Q3 2025 | -51% | +33 points |
| Q2 2025 | -65% | +52 points |
| Q1 2025 | -75% | +46 points |
| Q4 2024 | -523% | -427 points |
| Q3 2024 | -83% | +39 points |
DSS's operating margin was โ105% last quarter, down 40 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: โ$11.6B over the past year.
DSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.9M | -195% |
| Q1 2026 | -$330K | +$1.4M |
| Q4 2025 | -$1.6M | -$1.6M |
| Q3 2025 | -$8.1M | -$4.5M |
| Q2 2025 | $2M | +$5.4M |
| Q1 2025 | -$1.7M | +$463K |
| Q4 2024 | -$5K | -100% |
| Q3 2024 | -$3.6M | -$2.2M |
DSS has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
DSS Net Leverage
DSS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
DSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 7.2 | Oversold |
DSS's weekly RSI is 42 (neutral) and its Stochastic is 7 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
DSS PE vs Consumer Cyclical Sector
DSS has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
DSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.57 | 8.8% below |
| 20 week MA | $0.59 | 12% below |
| 50 week MA | $0.73 | 29% below |
| 100 week MA | $0.87 | 40% below |
| 200 week MA | $1.86 | 72% below |
DSS is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over DSS on returns for 2026, with the stronger performance.
DSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $160.5 | $118.3 | -26% |
| 2021 | $118.3 | $14.5 | -88% |
| 2022 | $14.5 | $3.44 | -76% |
| 2023 | $3.44 | $2.40 | -30% |
| 2024 | $2.40 | $0.90 | -63% |
| 2025 | $0.90 | $0.97 | +7.8% |
| 2026 YTD | $0.97 | $0.52 | -46% |
DSS has finished lower in five of the last six years. It's down 46% so far in 2026.